Research - NCI-CONNECTions
Rare brain and spine tumor research news and updates from NCI leading experts and collaborators. Includes articles on molecular profiling, genetic testing, and clinical studies and trials to develop better therapies.
-
Advancing the Science of Survivorship in Neuro-OncologyDr. Terri Armstrong joined fellow leaders in the field of cancer survivorship to discuss the needs of those living with brain and spine tumors, as well as goals for the future and research funding opportunities.
-
New Research Physician Helps Fight Rare Brain Tumors with KnowledgeDr. Byram Ozer joins NCI-CONNECT to help care for and educate patients, while bringing together medical professionals to learn new skills and treatment approaches.
-
Natural History Study for Rare Brain and Spine Tumors Enrolls One Thousand ParticipantsIn the six years since it began, the Natural History Study has amassed an enormous database of information that is helping to improve treatment and quality of life for patients with rare central nervous system cancers.
-
Mark Gilbert, M.D., Earns American Brain Tumor Association’s Joel A. Gingras Jr. AwardNCI Neuro-Oncology Branch Chief Mark Gilbert received the American Brain Tumor Association’s Joel A. Gingras Jr. Award for spearheading brain tumor research collaborations and expanding clinical trial access.
-
Progress to Advance Care, Treatments and Patient Outcomes for Brain TumorsRead about our advances in care, treatments and patient outcomes for brain and other central nervous systems tumors in honor of Brain Tumor Awareness Month.
-
New Research Shows How Patients with Brain and Spine Tumors are ImpactedFive nurses share data from the Natural History Study, which aims to better understand brain and spine tumors and uncover areas for further research.
-
Neuro-Oncology Branch Receives Awards at the 2021 SNO Annual MeetingTwo physicians share findings from the NCI-CONNECT Immunotherapy and Natural History Studies in award-winning abstracts.
-
First-in-Human Trial for People with Recurrent Rare CNS TumorsNCI-CONNECT launched a first-in-human phase I clinical trial for people with recurrent rare brain and spine tumors as a first step in the development of a novel drug for patients.
-
New Immunotherapy Study for GlioblastomaA clinical trial investigates immune checkpoint inhibitors with standard treatment in people with aggressive brain cancers to understand the immune system response and improve long-term outcomes.
-
An Immunotherapy Drug Trial Expands Across the Nation to Advance ResearchNCI-CONNECT launched an immunotherapy drug trial across its national network of collaborative institutions to reach more people with rare brain and spine tumors.